http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2022 on November 8, 2022
-
SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2022 on November 8, 2022
-
SOPHiA GENETICS Unveils Strategy to Drive Health Care Innovations at Inaugural Investor Day Event
-
SOPHiA GENETICS Unveils Strategy to Drive Health Care Innovations at Inaugural Investor Day Event
-
SOPHiA GENETICS Unveils Strategy to Drive Health Care Innovations at Inaugural Investor Day Event
-
SOPHiA GENETICS to Highlight Innovations and Announcements at Investor Day on September 20, 2022
-
SOPHiA GENETICS to Highlight Innovations and Announcements at Investor Day on September 20, 2022
-
SOPHiA GENETICS to Participate in Fireside Chat at 20th Annual Morgan Stanley Global Healthcare Conference
-
SOPHiA GENETICS to Participate in Fireside Chat at 20th Annual Morgan Stanley Global Healthcare Conference
-
SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2022
-
SOPHiA GENETICS Reports Financial Results for the Second Quarter of Fiscal 2022
-
SOPHiA GENETICS to Host Investor Day on September 20, 2022, in New York City
-
SOPHiA GENETICS to Host Investor Day on September 20, 2022, in New York City
-
SOPHiA GENETICS to Participate in Canaccord Genuity 42nd Annual Growth Conference
-
SOPHiA GENETICS to Participate in Canaccord Genuity 42nd Annual Growth Conference
-
SOPHiA GENETICS to Announce Financial Results for the Second Quarter of Fiscal 2022 on August 9, 2022
-
SOPHiA GENETICS to Announce Financial Results for the Second Quarter of Fiscal 2022 on August 9, 2022
-
SOPHiA GENETICS Publishes Results of 2022 Annual General Meeting
-
SOPHiA GENETICS Publishes Environmental, Social and Governance Impact Summary
-
SOPHiA GENETICS Launches New Solution to Advance Chronic Lymphocytic Leukemia Care, in Collaboration with IDIBAPS
-
SOPHiA GENETICS (SOPH) Provides Update on DEEP-Lung-IV Multimodal Clinical Study
-
SOPHiA GENETICS Provides an Update on its DEEP-Lung-IV Multimodal Clinical Study at ASCO 2022
-
SOPHiA GENETICS Announces Three Poster Presentations and One Online Publication Accepted at the 2022 American Society of Clinical Oncology Annual (ASCO) Meeting
-
SOPHiA GENETICS Announces Nomination of Jean-Michel Cosséry to Board of Directors
-
SOPHiA GENETICS to Attend and Host Investor Meetings at the J.P. Morgan 50th Annual Global Technology, Media, and Communications Conference
-
SOPHiA GENETICS to Attend and Host Investor Meetings at the J.P. Morgan 50th Annual Global Technology, Media, and Communications Conference
-
SOPHiA GENETICS (SOPH) Reaches Milestone of One Million Genomic Profiles Analyzed by the SOPHiA DDM Platform
-
SOPHiA GENETICS Hits Milestone of One Million Genomic Profiles Analyzed by the SOPHiA DDM™ Platform
-
SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2022 on May 10, 2022
-
SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2022 on May 10, 2022
-
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2021 Financial Results
-
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2021 Financial Results
-
SOPHiA GENETICS (SOPH) and REALM IDx to Collaborate on Cancer Research
-
SOPHiA GENETICS and REALM IDx Sign Letter of Intent to Collaborate in Accelerating Cancer Research
-
SOPHiA GENETICS (SOPH) HRD Solution Adopted in Asia Pacific
-
SOPHiA GENETICS HRD Solution Adopted in Asia Pacific
-
SOPHiA GENETICS to Participate in Fireside Chat at Barclays Global Healthcare Conference
-
SOPHiA GENETICS to Participate in Fireside Chat at Barclays Global Healthcare Conference
-
SOPHiA GENETICS Launches New Deep Learning Capabilities to Support the Detection of Homologous Recombination Deficiencies
-
SOPHiA GENETICS (SOPH) Announces First Japanese Institution to Utilize Myeloid Plus Solution
-
First Japanese Institution to Utilize SOPHiA GENETICS' Myeloid Plus Solution
-
SOPHiA GENETICS to Announce Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022
-
SOPHiA GENETICS to Announce Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022
-
Institut Paoli Calmettes Extends Partnership with SOPHiA GENETICS
-
SOPHiA GENETICS Appoints Ken Freedman as Chief Revenue Officer
-
SOPHiA GENETICS Reports Strong Traction in the Launch Phase of its DEEP-Lung-IV Multimodal Clinical Study
-
Executive Team Hires at SOPHiA GENETICS to Enhance BioPharma Business
-
SOPHiA GENETICS to Present at the 40th Annual J.P. Morgan Healthcare Conference
-
SOPHiA GENETICS to Present at the 40th Annual J.P. Morgan Healthcare Conference
-
SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study

